Early Hemodynamic Effects of Mydriatic Eye Drops in Preterm Infants
Frühe hämodynamische Effekte mydriatischer Augentropfen bei Frühgeborenen
American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e324-e330
DOI: 10.1055/a-1877-7868 ↗Auf einen Blick
Bei 26 Frühgeborenen wurden vor und nach mydriatischen Augentropfen keine signifikanten Veränderungen von Vitalzeichen, NIRS-Werten oder Echokardiographie gefunden. Unerwünschte Reaktionen traten nicht auf.
Fragestellung
Welche frühen hämodynamischen Effekte haben mydriatische Augentropfen bei Frühgeborenen nach ROP-Untersuchung?
Methode
Prospektive Studie bei Frühgeborenen <32 Gestationswochen; Messung von Vitalzeichen, NIRS und linksventrikulärer Funktion vor und nach 2,5 % Phenylephrin und 0,5 % Tropicamid; Vergleich der Werte.
Ergebnisse
32 Mydriasisprozeduren bei 26 Patient:innen. Keine signifikanten Unterschiede bei Herzfrequenz, Blutdruck, SpO2, zerebraler/mesenterialer Sättigung oder echokardiographischen Befunden vor vs. nach Gabe.
Schlussfolgerung der Autor:innen
Myriatische Augentropfen hatten bei Frühgeborenen keinen signifikanten Effekt auf frühe hämodynamische Parameter. Ein vorsichtiger Umgang zur Vermeidung systemischer Resorption könnte frühe systemische Effekte verhindern.
Kernaussagen
- Keine signifikanten Änderungen von Vitalzeichen nach Augentropfen
- Auch NIRS- und Echo-Messungen blieben unverändert
- Keine unerwünschte Reaktion in der Studienpopulation
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Emre Dincer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, University of Health Sciences, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Mydriatics, Ophthalmic Solutions, Infant, Premature, Tropicamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Objective
Mydriatic eye drops used for retinopathy of prematurity (ROP) examination can cause systemic effects, and there are case reports of serious adverse effects in the literature. In this prospective study, we aimed to evaluate the early hemodynamic effects of mydriatic eye drops to understand the possible mechanisms of adverse effects. Study Design Between December 2018 and March 2019, preterm babies less than 32 gestational weeks and who underwent ophthalmologic examination in our unit were included. The vital signs (heart rate, respiratory rate, oxygen saturation [SpO2], and blood pressure values), cerebral and mesenteric tissue saturation by near-infrared spectroscopy (NIRS), and left ventricular functions of infants were recorded before and after applying mydriatic eye drops (2.5% phenylephrine and 0.5% tropicamide). The data were compared statistically. Strict adherence to prevent systemic absorption of the eye drops was applied.
Results
Thirty-two mydriasis procedures were evaluated in 26 patients. The mean gestational age was 28.5 ± 1.7 weeks, and the mean birth weight was 943 ± 233 g. There were no significant differences in terms of vital signs of infants including heart rate, blood pressure, and oxygen saturation [SpO2] levels before and after eye-drop application. In addition, NIRS values showed no significant differences between before and after measurements. No significant differences were detected at echocardiographic evaluation performed before and after mydriatic administration. No adverse reaction was observed in the study population during the study.
Conclusion
This is the first study that evaluated the early hemodynamic effects of mydriatic eye drops used for ROP screening by vital signs, NIRS, and echocardiographic evaluation. Mydriatic eye drops have no significant effect on early hemodynamic parameters including vital signs, NIRS, and echocardiographic findings in preterm infants. We suggest that a cautious approach for avoiding the systemic absorption of these agents may prevent the possible early systemic effects in this high-risk population. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, University of Health Sciences, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, Türkiye.
- Department of Neonatology, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.
- Department of Pediatric Cardiology, University of Health Sciences, Kanuni Sultan Süleyman Research and Training Hospital, Istanbul, Türkiye.
- Department of Neonatology, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Türkiye.
- Department of Neonatology, University of Health Sciences, Kanuni Sultan Süleyman Research and Training Hospital, Istanbul, Türkiye.
- Department of Neonatology, Kanuni Sultan Suleyman Training and Research Hospital, İstanbul, Türkiye.
ORCID-Profile: Emre Dincer, Helen A Bornaun
Zitieren
APA
Dincer, E., Gonen, I., Bornaun, H. A., Yasa, B., Babayigit, A., Kurum, O., Bayramoğlu, S. E., & Cetinkaya, M. (2024). Early Hemodynamic Effects of Mydriatic Eye Drops in Preterm Infants. American Journal of Perinatology, 41(S 01 S 01), e324-e330. https://doi.org/10.1055/a-1877-7868
Vancouver
Dincer E, Gonen I, Bornaun HA, Yasa B, Babayigit A, Kurum O, et al. Early Hemodynamic Effects of Mydriatic Eye Drops in Preterm Infants. American Journal of Perinatology. 2024;41(S 01 S 01):e324-e330. doi:10.1055/a-1877-7868
BibTeX
@article{Dincer2024,
author = {Dincer, Emre and Gonen, Ilker and Bornaun, Helen A and Yasa, Beril and Babayigit, Aslan and Kurum, Ozge and Bayramoğlu, Sadık E and Cetinkaya, Merih},
title = {Early Hemodynamic Effects of Mydriatic Eye Drops in Preterm Infants},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {S 01 S 01},
pages = {e324--e330},
doi = {10.1055/a-1877-7868}
}
EUVIMED